MODERNA INC (MRNA)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for MRNA
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| MRNA | Director | 61 | ["Former CEO, Vifor Pharma","Former Global President, Pharmaceuticals and Vaccines, GSK","More than three decades of leadership and operating experience in the healthcare industry","Deep experience in the commercialization of pharmaceutical products","CEO of Vifor Pharmaceuticals from 2021 to 2023","Global President, Pharmaceuticals and Vaccines at GlaxoSmithKline from 2008 to 2017","Various leadership roles at Eli Lilly and Company for 20 years"] | [] | 2026 |
Biography sourced from the proxy statement filing.
Abbas Hussain, 61 Director since: 2024 2025 Attendance: 100% Committees Audit Product and Technology Education BSc from Loughborough Institute of Technology Why this director is valuable to Moderna Mr. Hussain brings more than three decades of leadership and operating experience in the healthcare industry to the Board, including deep experience in the commercialization of pharmaceutical products. He has also served as the CEO of a public company. Mr. Hussain s previous experience provides strategic insights and global operational expertise as we prepare to launch several additional products in the next few years. Other Public Boards Mallinckrodt Pharmaceuticals (2024- 2025) Vifor Pharmaceuticals (2021-2023) Teva Pharmaceuticals (2020-2021) CSL Limited (2018-2021) Cochlear Limited (2018-2021) Mr. Hussain was the CEO of Vifor Pharmaceuticals, a global specialty pharmaceutical company, from 2021 to 2023, when it was acquired by CSL. He previously served in various leadership roles as GlaxoSmithKline from 2008 to 2017, most recently as Global President, Pharmaceuticals and Vaccines. Earlier in his career, Mr. Hussain held various leadership roles at Eli Lilly and Company, spending 20 years with the company.